Industrial Farmaceutica Cantabria S.A.
- Address
- Barrio Solia N 30, Liano
Sponsor Overview
Specializations
Androgenetic Alopecia
Industrial Farmaceutica Cantabria S.A. supports clinical research in androgenetic alopecia, with a focus on treatments aimed at improving scalp hair density and slowing progressive hair loss. The sponsored studies address both efficacy and safety in this dermatologic condition.
- Hair regrowth
- Scalp hair density
- Topical and oral treatment options
The research activity includes evaluation of minoxidil-based approaches in women affected by hormone-related alopecia.
Female Pattern Hair Loss
The sponsor is also active in female androgenetic alopecia, a therapeutic area centered on chronic thinning of the scalp hair in women. Its trials reflect interest in clinical outcomes relevant to women with hormone-imbalanced hair loss.
- Women’s dermatology
- Hormone-related alopecia
- Non-vellus hair count
This area of research supports assessment of visible hair restoration and tolerability in a female population.
Minoxidil Formulations
Clinical interest extends to oral minoxidil and topical minoxidil, with attention to how different formulations are used in hair restoration research. The sponsor’s portfolio includes comparisons involving placebo and topical vehicle controls.
- Oral minoxidil
- Topical minoxidil
- Vehicle-controlled treatment
These studies align with therapeutic development in dermatology, particularly for patients seeking non-surgical options for scalp alopecia.
Dermatology and Hair Disorders
The sponsor’s clinical research landscape is concentrated in dermatology, especially disorders affecting the hair follicle and scalp. Its funded trials are directed toward measurable changes in hair growth and treatment response.
- Hair follicle disorders
- Scalp conditions
- Clinical evaluation of hair growth
Research activity in this field supports therapeutic interest in chronic, non-scarring forms of alopecia.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Bioavailability Study of Oral Minoxidil 1 mg in Androgenetic Alopecia: Randomized Crossover Trial in Healthy Volunteers Under Fasting Conditions |  Spain | Not Recruiting |
| Evaluation of Oral Minoxidil 1 mg Efficacy and Safety in Female Androgenetic Alopecia: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial |  Germany Italy Portugal Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 23 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases2 trials247 other sponsors
- 2.Hormonal diseases1 trial89 other sponsors
Partnered Research Centres
23 centres- Address
- Kaiser-Joseph-Str. 262, 79098 Freiburg im Breisgau
- Address
- Via Pietro Albertoni 15, 40138 Bologna
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
- Address
- Alleestrasse 80, Innenstadt, 44793 Bochum
- Address
- Messberg 4, Hamburg-Altstadt, 20095 Hamburg
- Address
- Platz Der Deutschen Einheit 4, 63065 Offenbach Am Main
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Industrial Farmaceutica Cantabria S.A..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.